Company Data
Mineralys Therapeutics Inc.
Ticker
MLYS
Current Price
$27.7 -2.84%
Market Cap
$2.2B
Price Target
Refer to Report
Volume
473.3K
52wk Range
$8.685 - $47.65
Overview
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.